Vycor Medical, Inc. (VYCO)
USD 0.07
(0.0%)
USD 0.07
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 29.43 Thousand | -217.01 Thousand | 21.36 Thousand | -248.79 Thousand | 7221.00 | -260.32 Thousand |
| Net Income | -69.69 Thousand | -404.91 Thousand | -435.66 Thousand | -822.48 Thousand | -796.2 Thousand | -1.37 Million |
| Depreciation & Amortization | 60.75 Thousand | 61.4 Thousand | 68.41 Thousand | 57.89 Thousand | 69.43 Thousand | 177.35 Thousand |
| Deferred income taxes | -27.45 Thousand | - | -108.82 Thousand | - | - | 315.24 Thousand |
| Stock-based compensation | 10.14 Thousand | 185.61 Thousand | 341.09 Thousand | 520 Thousand | 534.94 Thousand | 625.62 Thousand |
| Change in working capital | 27.45 Thousand | -72.96 Thousand | 156.33 Thousand | 42.3 Thousand | 184.09 Thousand | 816.00 |
| Other non-cash items | 28.22 Thousand | 13.85 Thousand | -1.00 | -46.51 Thousand | 14.94 Thousand | 1.00 |
| Investing Cash Flow | -9386.00 | -2780.00 | -38.37 Thousand | -52.47 Thousand | -58.25 Thousand | -63.52 Thousand |
| Investments in PPE | -9386.00 | -2780.00 | -38.37 Thousand | -62.05 Thousand | -58.25 Thousand | -63.52 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | 9574.00 | 2456.00 | - |
| Financing Cash Flow | 211.00 | 165.88 Thousand | 61.94 Thousand | 286.55 Thousand | 40.09 Thousand | 200.42 Thousand |
| Debt repayment | -62.91 Thousand | -6611.00 | -6655.00 | -2048.00 | -40.09 Thousand | -200.42 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | 225 Thousand |
| Other Financing Activities | 211.00 | 172.5 Thousand | 68.6 Thousand | 288.6 Thousand | 40.09 Thousand | -24.57 Thousand |
| Accounts receivables | -59.02 Thousand | -30.1 Thousand | 33.14 Thousand | 115.31 Thousand | -20.55 Thousand | -147.04 Thousand |
| Accounts payables | -82.24 Thousand | -27.67 Thousand | 48.61 Thousand | -66.3 Thousand | 158.97 Thousand | -48.36 Thousand |
| Inventory | 14.72 Thousand | -56.86 Thousand | -38.78 Thousand | 14.69 Thousand | -19.96 Thousand | 4482.00 |
| Other working capital | 126.54 Thousand | 41.68 Thousand | 113.36 Thousand | -21.4 Thousand | 65.64 Thousand | 191.74 Thousand |
| Cash at beginning of period | 37.03 Thousand | 90.94 Thousand | 46 Thousand | 60.71 Thousand | 86.48 Thousand | 206.21 Thousand |
| Cash at end of period | 57.29 Thousand | 37.03 Thousand | 90.94 Thousand | 46 Thousand | 72.23 Thousand | 86.48 Thousand |
| Capital Expenditure | -9386.00 | -2780.00 | -38.37 Thousand | -62.05 Thousand | -58.25 Thousand | -63.52 Thousand |
| Effect of forex changes on cash | 1.00 | 1.00 | - | 2.00 | -3301.00 | 3692.00 |
| Net cash flow / Change in cash | 20.25 Thousand | -53.9 Thousand | 44.93 Thousand | -14.71 Thousand | -14.24 Thousand | -119.73 Thousand |
| Free Cash Flow | 20.04 Thousand | -219.79 Thousand | -17 Thousand | -310.84 Thousand | -51.03 Thousand | -323.84 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -9989.00 | -30.5 Thousand | -69.69 Thousand | -93.05 Thousand | -51.9 Thousand | 68.4 Thousand |
| Depreciation & Amortization | 15.68 Thousand | 15.62 Thousand | 60.75 Thousand | 15.1 Thousand | 15.22 Thousand | 15.07 Thousand |
| Deferred income taxes | - | - | -27.45 Thousand | - | - | - |
| Stock-based compensation | - | 2364.00 | 10.14 Thousand | 2364.00 | 2363.00 | 2364.00 |
| Change in working capital | 80.39 Thousand | 9646.00 | 27.45 Thousand | 81.24 Thousand | 20.68 Thousand | -73.29 Thousand |
| Other non-cash items | 29.69 Thousand | 29.59 Thousand | 28.22 Thousand | -143.00 | 424.00 | 784.00 |
| Investing Cash Flow | - | 662.00 | -9386.00 | -5904.00 | -4024.00 | 254.00 |
| Investments in PPE | -86.03 Thousand | - | -9386.00 | -5904.00 | -3482.00 | - |
| Acquisitions | - | 662.00 | - | - | -542.00 | 254.00 |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 662.00 | - | - | -542.00 | 254.00 |
| Financing Cash Flow | -10.59 Thousand | -15.98 Thousand | 211.00 | -11.36 Thousand | 32.87 Thousand | -7986.00 |
| Debt repayment | -10.59 Thousand | -15.98 Thousand | -62.91 Thousand | -11.36 Thousand | -32.87 Thousand | -7986.00 |
| Dividends payments | - | -162.18 Thousand | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -10.59 Thousand | 146.2 Thousand | 211.00 | -11.36 Thousand | 65.75 Thousand | -7986.00 |
| Accounts receivables | -8707.00 | -33.7 Thousand | -59.02 Thousand | 40.03 Thousand | 27.28 Thousand | -104.65 Thousand |
| Accounts payables | 6911.00 | 30.05 Thousand | -82.24 Thousand | 4072.00 | -9634.00 | -37.45 Thousand |
| Inventory | 3415.00 | 12.41 Thousand | 14.72 Thousand | -29.4 Thousand | 14.75 Thousand | 11.87 Thousand |
| Other working capital | 78.77 Thousand | 874.00 | 126.54 Thousand | 66.53 Thousand | -11.71 Thousand | 56.93 Thousand |
| Cash at beginning of period | 43.85 Thousand | 57.29 Thousand | 37.03 Thousand | 69.05 Thousand | 53.4 Thousand | 47.8 Thousand |
| Cash at end of period | 119.29 Thousand | 43.85 Thousand | 57.29 Thousand | 57.29 Thousand | 69.05 Thousand | 53.4 Thousand |
| Capital Expenditure | -86.03 Thousand | - | -9386.00 | -5904.00 | -3482.00 | - |
| Effect of forex changes on cash | - | - | 1.00 | -1.00 | 1.00 | 1.00 |
| Net cash flow / Change in cash | 75.43 Thousand | -13.43 Thousand | 20.25 Thousand | -11.76 Thousand | 15.65 Thousand | 5599.00 |
| Free Cash Flow | - | 1887.00 | 20.04 Thousand | -396.00 | -16.68 Thousand | 13.33 Thousand |
CLNNW
MAGN
BKKT
NET
RDOR3
0R2Y